CD8A and neoplasm: CD8_C4_IFIT1 and Treg_C4_LAIR2 predominantly originated from tumor samples, while CD8_C3_CXCL13 and CD8_C6_MS4A6A were primarily derived from both tumor and HGIN samples (Supplementary Figure 4C).